Budesonide Formoterol Rotacap

Product Description

Budeflo 400 Rotacaps

(Budesonide 400 mcg + Formoterol Fumarate 6 mcg Rotacaps)

Composition (per rotacap):

• Budesonide IP 400 mcg

• Formoterol Fumarate Dihydrate IP 6 mcg
  (For inhalation use only with a Rotahaler device)

Description:

Budeflo 400 Rotacaps combine Budesonide, a potent inhaled corticosteroid (ICS), and Formoterol, a long-acting beta-2 agonist (LABA), designed for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

• Budesonide controls airway inflammation and hyperresponsiveness.

• Formoterol provides rapid and sustained bronchodilation.

This dual-action formulation helps manage symptoms, improves lung function, and reduces the frequency of asthma and COPD exacerbations.

Indications:

• Moderate to severe persistent asthma

• Maintenance treatment of COPD, including chronic bronchitis and emphysema

• For patients requiring high-dose ICS + LABA combination therapy

Key Benefits:

High-strength formulation for better control of severe airway diseases
Reduces airway inflammation and prevents bronchospasm
Quick onset of action and long-lasting relief
Improves lung function, physical activity, and quality of life
Convenient twice-daily dosing

Dosage & Administration:

• Usual Dose: One rotacap twice daily, or as directed by a physician

• For inhalation use only with a Rotahaler

• Do not swallow the capsule

• Rinse mouth after inhalation to reduce the risk of oral thrush

Storage:

• Store below 25C in a dry place

• Protect from light and moisture

• Keep out of reach of children